LWCFA
XLRN
Loring Wolcott & Coolidge Fiduciary Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-330
| Closed | -$57K | – | 787 |
|
2021
Q3 | $57K | Sell |
330
-21
| -6% | -$3.63K | ﹤0.01% | 451 |
|
2021
Q2 | $44K | Buy |
+351
| New | +$44K | ﹤0.01% | 482 |
|
2021
Q1 | – | Sell |
-337
| Closed | -$43K | – | 767 |
|
2020
Q4 | $43K | Hold |
337
| – | – | ﹤0.01% | 445 |
|
2020
Q3 | $38K | Hold |
337
| – | – | ﹤0.01% | 424 |
|
2020
Q2 | $32K | Hold |
337
| – | – | ﹤0.01% | 415 |
|
2020
Q1 | $30K | Hold |
337
| – | – | ﹤0.01% | 422 |
|
2019
Q4 | $18K | Hold |
337
| – | – | ﹤0.01% | 548 |
|
2019
Q3 | $13K | Hold |
337
| – | – | ﹤0.01% | 553 |
|
2019
Q2 | $14K | Hold |
337
| – | – | ﹤0.01% | 544 |
|
2019
Q1 | $16K | Hold |
337
| – | – | ﹤0.01% | 537 |
|
2018
Q4 | $15K | Hold |
337
| – | – | ﹤0.01% | 543 |
|
2018
Q3 | $19K | Hold |
337
| – | – | ﹤0.01% | 500 |
|
2018
Q2 | $16K | Hold |
337
| – | – | ﹤0.01% | 519 |
|
2018
Q1 | $13K | Hold |
337
| – | – | ﹤0.01% | 572 |
|
2017
Q4 | $14K | Hold |
337
| – | – | ﹤0.01% | 550 |
|
2017
Q3 | $13K | Hold |
337
| – | – | ﹤0.01% | 546 |
|
2017
Q2 | $11K | Hold |
337
| – | – | ﹤0.01% | 543 |
|
2017
Q1 | $9K | Hold |
337
| – | – | ﹤0.01% | 559 |
|
2016
Q4 | $9K | Hold |
337
| – | – | ﹤0.01% | 543 |
|
2016
Q3 | $12K | Hold |
337
| – | – | ﹤0.01% | 534 |
|
2016
Q2 | $11K | Buy |
+337
| New | +$11K | ﹤0.01% | 539 |
|